Open access · CC-BY
via OpenAlex
Prevalence of stroke and metabolic disorders in the middle-aged and elderly Chinese with type 2 diabetes
Zhang Xuebing, MU Yi-ming, Yan Wenhua, Jianming Ba, Hongmei Li
Chinese Medical Journal · 2014 · ▲ 16 citations
Abstract
BACKGROUND: Stroke is now the most prevalent and debilitating disease affecting diabetic population in China. The study aimed to investigate the prevalence of stroke and metabolic disorders in the middle-aged and elderly Chinese with type 2 diabetes. METHODS: A total of 4 629 subjects with type 2 diabetes (males: 1 917; females: 2 712) aged ≥ 40 years from Shijingshan district, Beijing, China from November 2011 to August 2012 were included in the study. Data on demographic information, lifestyle, history of diabetes mellitus, stroke, coronary heart disease, hypertension, and dyslipidemia were collected. The oral glucose tolerance test or a standard meal test was performed. Non-fatal stroke was reported by the subjects. The 2-tailed test was used, and P < 0.05 was regarded as statistically significant. RESULTS: Prevalence of stroke in the subjects with type 2 diabetes was 5.5%. The prevalence of smoking, overweight or obesity, hypertension, and dyslipidemia was 41.0%, 65.8%, 67.4%, and 52.0% in males, and 2.2%, 65.5%, 69.5%, and 57.6% in females. Multivariate Logistic regression analysis showed that increased age, hypertension, diabetic duration, and overweight or obesity were positively correlated with stroke in the population with type 2 diabetes, whereas high-density lipoprotein cholesterol level was negatively correlated with stroke. After adjustment for age and gender, the odds ratio values of stroke in subjects having 1, 2 or ≥3 of 4 risk factors, including smoking, overweight or obesity, hypertension and dyslipidemia, were 2.302 (95% CI: 0.789-6.712), 4.089 (95% CI: 1.470-11.373), 6.023 (95% CI: 2.176-16.666), compared with subjects without any of the above 4 risk factors. CONCLUSIONS: The prevalence of stroke was higher in middle-aged and elderly Chinese with type 2 diabetes than that in the general population. With the aggregation of risk factors, the prevalence of stroke increased.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3760/cma.j.issn.0366-6999.20141018
- Canonical
- link ↗
- Fetched
- 2026-10-20 MST
Cite this
APA
Xuebing, Z., Yi-ming, M., Wenhua, Y., Ba, J., & Li, H. (2014). Prevalence of stroke and metabolic disorders in the middle-aged and elderly Chinese with type 2 diabetes. <em>Chinese Medical Journal</em>. https://doi.org/10.3760/cma.j.issn.0366-6999.20141018
Vancouver
Xuebing Z, Yi-ming M, Wenhua Y, Ba J, Li H. Prevalence of stroke and metabolic disorders in the middle-aged and elderly Chinese with type 2 diabetes. Chinese Medical Journal. 2014. doi:10.3760/cma.j.issn.0366-6999.20141018.
BibTeX
@article{zhang2014Preval,
title = {Prevalence of stroke and metabolic disorders in the middle-aged and elderly Chinese with type 2 diabetes},
author = {Zhang Xuebing and MU Yi-ming and Yan Wenhua and Jianming Ba and Hongmei Li},
journal = {Chinese Medical Journal},
year = {2014},
doi = {10.3760/cma.j.issn.0366-6999.20141018},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Diabetes Care 2004
Open access · OA
Metabolic Syndrome as a Predictor of All-Cause and Cardiovascular Mortality in Type 2 Diabetes
International Journal of Advanced Research in Medicine 2023
Open access · OA
Assessment of metabolic syndrome in type 2 diabetes mellitus
Cardiovascular Diabetology 2007
Open access · CC-BY
Impact of the individual components of the metabolic syndrome and their different combinations on the prevalence of atherosclerotic vascular disease in type 2 diabetes: the Diabetes in Germany (DIG) study
Medical Forum Monthly 2024
Open access · OA
Metabolic Syndrome in Type 2 Diabetes Mellitus
International Journal of Advances in Medicine 2016
Open access · OA
The study of prevalence of hyperuricemia and metabolic syndrome in type 2 diabetes mellitus
Journal of Biosciences and Medicines 2023
Open access · CC-BY